We bring together innovators and investors to commercialise the companies that will form the longevity economy.
There are already 100+ rejuvenation biotechs working on unique therapies and building R&D pipelines to increase healthspan and lifespan.
At the same time, all around the world, innovators are releasing nanobots, reprogramming nerve signals and applying AI to create exciting and scalable contributions to human Longevity.
Longevity science is here; so are the risks and so are the rewards.
We look beyond rejuvenation therapies to embrace other technologies that participate in the Longevity investment category: Agetech, xeno, biomarkers, AI, bioprinting, neuroceuticals, GRAS supplements …
There are multiple technologies that contribute to the reduction of morbidity and the extension of lifespan.
Founder & CEO
Phil is a seasoned marketing and business development professional. He is also Editor-in-Chief of Longevity.Technology and oversees content strategy, market research, and deal-flow.
In his career, Phil has held c-level management positions across multiple tech sectors: Longevity; IoT; AI; Medical Devices; Biopharma; 3D Manufacturing; Smartgrid and Sustainability.
In over 30 years of experience in health markets, George has demonstrated many years of success working with major fast moving consumer goods (FMCG) and medical companies.
He as pre and post IPO experience, operating as a non-executive chairman for start-ups in health tech: First Longevity; Trueinvivo; TestCard.
After completion of an MBA at Cambridge Tom co-founded SyndicateRoom – a data driven Venture Capital fund which has gone-on to be a leading platform in UK investment
His invaluable skills include: Early-stage Venture Finance, Product Development, Project / Program Management, Data Analysis, Process Implementation, and managing startups.
Chairman & Founder,
Burnbrae Group, Juvenescence
Aubrey de Grey
Founding Core Faculty & Lead, Synthetic Biology, Harvard University
Chief Executive Officer Insilico Medicine, Inc
UK Lead / Advisor,
Co-Founder and CEO,
João Pedro de Magalhães
Professor Institute of Ageing and Chronic Disease University of Liverpool
Head of Research
Marketing and Design Manager